FAQ

Glucagon

Known as: Glukagon, Glucagon [Chemical/Ingredient], Glucagon (1-29) 
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by… (More)

Topic mentions per year

Topic mentions per year

1950-2017
020040060080019502016

Related topics

Related topics

41 relations
BradycardiaCell Proliferation Regulatory ProcessDrug AllergyGCG gene
(More)

Broader (5)

Gastrointestinal AgentsGonadorelinHormonesInsulin
(More)

Narrower (7)

GlucaGenS 23521glucagon (1-17)glucagon (1-21)
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Glucagon
Drug Allergy
physiological aspects
agonists
Hypoglycemia
Islets of Langerhans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
BACKGROUND & AIMS Glucagon-like peptide-1-based therapy is gaining widespread use for type 2 diabetes, although there are… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
BACKGROUND The glucagon-like peptide 1 receptor (GLP-1R) is believed to mediate glucoregulatory and cardiovascular effects of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure II
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
BACKGROUND Glucose-insulin-potassium infusions are beneficial in uncomplicated patients with acute myocardial infarction (AMI… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
The stimulation of insulin vs. inhibition of glucagon secretion in relation to the antidiabetic action of glucagon-like peptide-1… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Glucagon, the counter-regulatory hormone to insulin, is secreted from pancreatic alpha cells in response to low blood glucose. To… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
BACKGROUND Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Adiponectin (Ad) is a hormone secreted by adipocytes that regulates energy homeostasis and glucose and lipid metabolism. However… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
To elucidate the causes of the diminished incretin effect in type 2 diabetes mellitus we investigated the secretion of the… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
We examined the effect of intravenously infused glucagon-like peptide 1 (GLP-1) on subjective appetite sensations after an energy… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Glucagon-like peptide-1 7-36: a physiological incretin in man.
The physiological role of glucagon-like peptide-1 7-36 amide (GLP-1 7-36) in man was investigated. GLP-1 7-36-like… (More)
Is this relevant?